❗Survey about to close❗ Oncology nurse in the US? Tell us how your role and day-to-day activities have evolved, especially after the pandemic. ⏰takes 10 mins 🤫All answers are anonymous Go to survey 👉 ow.ly/BzaX50ShTmn #MedEd #Nurse #NurseTwitter #RN #OncologyNursing

Did you catch this #UpperGICancer update from #ASCO24? GI CONNECT experts share their views on new data presented at the congress ⬇️ ow.ly/xoIF50ShOQ4 #MedEd #GastricCancer #OncologyNursing

⚠️Survey closing⚠️ Oncology nurses in the US - tell us how your role and day-to-day activities have evolved in recent years. ⏰takes 10 mins 🤫All answers are anonymous Go to survey 👉 ow.ly/WKKo50ShUaS #MedEd #Nurse #NurseTwitter #RN #OncologyNursing

Missed #ASCO24 this year? Don't worry, we've got you covered! GI CONNECT members shared #UpperGI & #LowerGI cancer updates, live from the congress. Hear what they have to say on new, practice-changing data... 👉 ow.ly/ZVQr50ShPha #MedED #Oncology #MedTwitter

GUIDE is a Communication Framework to support oncology nurses caring for pts with #colorectalcancer. It was published in the Clinical Journal of @OncologyNursing 📰 Read the e-pub here👉 ow.ly/iTLQ50Smu6L #oncologynursing #MedEd #CRC Supported by an IME grant from Bayer

🎉 #ESMOGI24 starts tomorrow! See the abstracts 👇 x.com/myesmo/status/… #MedEd

Congratulations to the CONNECT group members announced as ESMO - Eur. Oncology #ESMOGI24 ambassadors! 👏 x.com/myesmo/status/… #MedEd #CRC #GIoncology

Get the nurses' perspective on the rising incidence of young-onset #colorectalcancer from #NursePractitioner Natasha Pinheiro. Watch the video and download the accompanying slides ▶️ ow.ly/azT550SmwwP #MedEd #EAOCRC #CRCSM #oncologynursing

Should GI oncologists seek #dermatology input for patients with skin toxicity from MKIs? Medical experts share their experiences of managing skin side effects from multikinase inhibitors in this short podcast episode ⬇️ ow.ly/zkHe50So9yh #MedEd #CRC #AEs #OncologyNursing

Opinion piece on #ESMODailyReporter from Angela Lamarca 👏 Dr. Lamarca is a member of one of our partner CONNECT groups, NET CONNECT, focusing on neuroendocrine tumours. #MedEd #HCC x.com/myesmo/status/…

Members of GI CONNECT and NET CONNECT coming together at #ESMOGI24 👇 (🎙️ @RachelReichelm2 recently recorded a new podcast episode on 'Regional differences in NETs', check it out here: cor2ed.com/net-connect/pr… ) #MedEd x.com/dralanburguete…

📣 Oncology nurses 📣 Download your free infographic on flexible dosing of oral treatments in mCRC to manage adverse events ⬇️⬇️⬇️ ow.ly/Ih7A50Soo2P #MedEd #oncologynursing #crc

Did you catch the update from #ASCO24 from our partner physician group @giconnect_Info? #GIoncology experts shared their views on new data emerging from the congress. Watch their video updates on #UpperGI cancer & #LowerGI cancer 👇 ow.ly/qowe50SFaPl #MedEd #RN

👩‍⚕️ Meet the experts GI NURSES CONNECT is a group of international experts in GI #oncologynursing. They identify educational needs & develop #MedEd programmes for #HCPs worldwide 👏 #cancernurse Find out more: ow.ly/Tcwv50SFfEt

Interesting study findings on PCSK2 in GI neuroendocrine tumours ⬇️ Thanks for sharing, NET CONNECT #GIoncology #MedTwitter #MedEd ow.ly/GRoW50SKrg3

The role of liquid biopsy is evolving. PRECISION ONCOLOGY CONNECT expert Assoc. Prof. Umberto Malapelle reviews this topic 👇👇👇 ow.ly/PTfc50SKrAV #MedEd

Come and see our latest #OncologyNursing #MedEd programmes on topics including: 💠 Flexible dosing of oral treatments in metastatic #colorectalcancer 💠 Managing skin toxicity from multikinase inhibitors 💠 Young-onset #CRC 👉ow.ly/4P8U50SKrTb

📣Flexible dosing of oral treatments in metastatic #CRC - downloadable infographic guides 💠Developed by GI oncology experts 💠Free to download 💠Use as a reference and share with your colleagues 👉 ow.ly/Oiw950SKYwx #MedEd #CRCSM #OncologyNursing

📣 New #LowerGI cancer data from #ESMO24 📣 Profs. Chiara Cremolini & Hans Prenen joined us at the congress to share their insights on new data from POD1UM-303/InterAACT 2, RAMTAS/IKF643 & POCHI trials. 📺Watch their video update Supported by Bayer #Meded #CRC

🚨 New #LowerGI cancer data from #ESMO24 🚨 Profs. Chiara Cremolini & Hans Prenen joined us at the congress to each share their insights on new rectal & colorectal cancer data from NICHE-2, NICHE-3 & IMHOTEP trials. 📺Watch their video update Supported by Bayer #Meded #CRC